SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-269490
Filing Date
2021-09-10
Accepted
2021-09-10 07:55:05
Documents
2
Period of Report
2021-09-10
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d218466d8k.htm 8-K 17686
2 EX-99.1 d218466dex991.htm EX-99.1 9402
  Complete submission text file 0001193125-21-269490.txt   28205
Mailing Address 303 WYMAN STREET SUITE 300 WALTHAM MA 02451
Business Address 303 WYMAN STREET SUITE 300 WALTHAM MA 02451 (781) 530-3600
Adagio Therapeutics, Inc. (Filer) CIK: 0001832038 (see all company filings)

IRS No.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40703 | Film No.: 211245879
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences